| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Chief Financial Officer | Chief Financial Officer +1 more
2 companies
Robertson Michelle is an EVP, Chief Financial Officer at Editas Medicine, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 2 sells.
Estimated insider holdings value: $388K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28, 2021 | EDIT Editas Medicine, Inc. | Chief Financial Officer | Sale+OE | 2,500 | $50.00 | $125,000.00 | -8.0% | +31.5% | -71.7% | |
| Jan 12, 2021 | EDIT Editas Medicine, Inc. | Chief Financial Officer | Sell | 1,568 | $78.27 | $122,727.36 | -7.8% | - | - |